Effect of Short-chain Fatty Acids on Epstein-Barr Virus Early and Viral Capsid Antigen Induction in P3HR-1 Cells
Overview
Authors
Affiliations
The effects of short-chain fatty acids were assayed for their capacity to induce Epstein-Barr virus (EBV) from the EBV genome-carrying human lymphoblastoid P3HR-1 cells. Not only the n-butyric acid, the activity of which is now well established, but also the n-valeric acid was found to induce EBV-associated early antigen (EA) and viral capsid antigen (VCA) at an appreciable level. Similarly, i-valeric acid showed a considerably lower, but significant, level of this activity, while the i-butyric acid was inactive. All other fatty acids with either a chain shorter than butyric or longer than valeric showed only a marginal effect or none at all. Thus, the decisive factor for EBV-inducing capacity of the fatty acids concerns adequate length and configuration of the basic structure of the molecules.
Gorres K, Daigle D, Mohanram S, Miller G J Virol. 2014; 88(14):8028-44.
PMID: 24807711 PMC: 4097796. DOI: 10.1128/JVI.00722-14.
Growth of B95-8 cells and expression of Epstein-Barr virus lytic phase in serum-free medium.
Shaw J, Petit R, Leung K J Virol. 1987; 61(12):4033-7.
PMID: 2824833 PMC: 256028. DOI: 10.1128/JVI.61.12.4033-4037.1987.
Asai S, Nakamura Y, Yamamura M, Ikezawa H, Namikawa I Arch Virol. 1991; 119(3-4):291-6.
PMID: 1652240 DOI: 10.1007/BF01310678.